Urano T, Emkey R, Feig L A
Department of Biochemistry, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
EMBO J. 1996 Feb 15;15(4):810-6.
Ral proteins (RalA and RalB) comprise a distinct family of Ras-related GTPases (Feig and Emkey, 1993). Recently, Ral-GDS, the exchange factor that activates Ral proteins, has been shown to bind specifically to the activated forms of RasH, R-Ras and Rap1A, in the yeast two-hybrid system. Here we demonstrate that although all three GTPases have the capacity to bind Ral-GDS in mammalian cells, only RasH activates Ral-GDS. Furthermore, although constitutively activated Ra1A does not induce oncogenic transformation on its own, its expression enhances the transforming activities of both RasH and Raf. Finally, a dominant inhibitory form of RalA suppresses the transforming activities of both RasH and Raf. These results demonstrate that activation of Ral-GDS and thus its target, Ral, constitutes a distinct downstream signaling pathway from RasH that potentiates oncogenic transformation.
Ral蛋白(RalA和RalB)构成了一个独特的Ras相关GTP酶家族(费格和恩基,1993年)。最近,在酵母双杂交系统中,激活Ral蛋白的交换因子Ral-GDS已被证明能特异性结合RasH、R-Ras和Rap1A的激活形式。在此我们证明,虽然这三种GTP酶在哺乳动物细胞中都有结合Ral-GDS的能力,但只有RasH能激活Ral-GDS。此外,虽然组成型激活的Ra1A自身并不诱导致癌转化,但其表达增强了RasH和Raf的转化活性。最后,RalA的显性抑制形式抑制了RasH和Raf的转化活性。这些结果表明,Ral-GDS及其靶标Ral的激活构成了一条与RasH不同的下游信号通路,该通路增强了致癌转化。